Literature DB >> 12508627

DOTS versus self administered therapy (SAT) for patients of pulmonary tuberculosis: a randomised trial at a tertiary care hospital.

Monika Tandon1, M Gupta, S Tandon, K B Gupta.   

Abstract

Tuberculosis is a major public health problem in a developing country like India, it is made worse by poor adherence to and frequent interruption of treatment. Treatment of tuberculosis requires strict discipline in order to eradicate mycobacteria and to cure the disease. In the present study we have conducted a randomized control trial, to compare the effectiveness of Directly Observed Therapy Short Course (DOTS) versus Self Administered Therapy (SAT) in a tertiary care hospital.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12508627

Source DB:  PubMed          Journal:  Indian J Med Sci        ISSN: 0019-5359


  5 in total

1.  Comparison of Directly Observed Treatment Short Course (DOTS) with Self-Administered Therapy in Pulmonary Tuberculosis in Udupi District of Southern India.

Authors:  Amrita Parida; K L Bairy; Bharti Chogtu; Rahul Magazine; Sudha Vidyasagar
Journal:  J Clin Diagn Res       Date:  2014-08-20

2.  Clinical and laboratory observations of tuberculosis at a Mumbai (India) clinic.

Authors:  D Gothi; J M Joshi
Journal:  Postgrad Med J       Date:  2004-02       Impact factor: 2.401

Review 3.  Directly observed therapy for treating tuberculosis.

Authors:  Jamlick Karumbi; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2015-05-29

4.  An attempt to reproduce a previous meta-analysis and a new analysis regarding the impact of directly observed therapy on tuberculosis treatment outcomes.

Authors:  Brian McKay; Maria Castellanos; Mark Ebell; Christopher C Whalen; Andreas Handel
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

5.  Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.

Authors:  Narges Alipanah; Leah Jarlsberg; Cecily Miller; Nguyen Nhat Linh; Dennis Falzon; Ernesto Jaramillo; Payam Nahid
Journal:  PLoS Med       Date:  2018-07-03       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.